Literature DB >> 1427977

Interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure.

F Goto1, K Goto, T Miyata, S Ohkawara, T Takao, S Mori, S Furukawa, T Maeda, S Iwanaga, Y Shimonishi.   

Abstract

A rabbit interleukin-1 (IL-1) inhibitor in inflammatory peritoneal exudate cells was purified to apparent homogeneity. This inhibitor was extracted from exudate cells of the 24-hr stage of casein-induced peritoneal inflammation and purified using isoelectrofocusing (IEF), gel filtration, followed in this order by high-performance liquid chromatography (HPLC) steps with hydroxylapatite and anionic ion exchanger. The purified factor showed a single band on silver-stained SDS-PAGE. This molecule of MW 19,000 and pI 5.5 inhibited the binding of both IL-1 alpha and beta to receptors on a thymoma cell line, EL-4 and a B-cell line, 70Z/3. We determined its primary structure by a combination of peptide chemistry and molecular cloning. The inhibitor was synthesized as a precursor composed of 177 amino acids and was processed to a mature molecule of 143 amino acids. The N-terminal amino acid of the mature inhibitor was N-acetyl-methionine residue. The deduced amino acid sequence of the inhibitor showed a 77% homology to the human IL-1 receptor antagonist (IL-1Ra) and essentially the same mode of action as seen with human IL-1Ra. We consider that this inhibitor is a rabbit counterpart of human IL-1Ra, although there are differences with respect to the molecular structure; the N-terminus of the mature rabbit IL-1Ra at a position of nine amino acids downstream from that of human IL-1Ra.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427977      PMCID: PMC1421625     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Two high-affinity interleukin 1 receptors represent separate gene products.

Authors:  R Chizzonite; T Truitt; P L Kilian; A S Stern; P Nunes; K P Parker; K L Kaffka; A O Chua; D K Lugg; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Second-strand cDNA synthesis with E. coli DNA polymerase I and RNase H: the fate of information at the mRNA 5' terminus and the effect of E. coli DNA ligase.

Authors:  J M D'Alessio; G F Gerard
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

3.  Rapid analysis of amino acids using pre-column derivatization.

Authors:  B A Bidlingmeyer; S A Cohen; T L Tarvin
Journal:  J Chromatogr       Date:  1984-12-07

4.  Evidence for different interleukin 1 receptors in murine B- and T-cell lines.

Authors:  K Bomsztyk; J E Sims; T H Stanton; J Slack; C J McMahan; M A Valentine; S K Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Authors:  S P Eisenberg; R J Evans; W P Arend; E Verderber; M T Brewer; C H Hannum; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

6.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

7.  Factor IX Kawachinagano: impaired function of the Gla-domain caused by attached propeptide region due to substitution of arginine by glutamine at position -4.

Authors:  M Sugimoto; T Miyata; S Kawabata; A Yoshioka; H Fukui; S Iwanaga
Journal:  Br J Haematol       Date:  1989-06       Impact factor: 6.998

8.  Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.

Authors:  E V Granowitz; B D Clark; J Mancilla; C A Dinarello
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.

Authors:  C J McMahan; J L Slack; B Mosley; D Cosman; S D Lupton; L L Brunton; C E Grubin; J M Wignall; N A Jenkins; C I Brannan
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

10.  Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation.

Authors:  O Ramilo; X Sáez-Llorens; J Mertsola; H Jafari; K D Olsen; E J Hansen; M Yoshinaga; S Ohkawara; H Nariuchi; G H McCracken
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  4 in total

1.  Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits.

Authors:  T Fukumoto; A Matsukawa; S Ohkawara; K Takagi; M Yoshinaga
Journal:  Inflamm Res       Date:  1996-09       Impact factor: 4.575

2.  Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits.

Authors:  A Matsukawa; S Ohkawara; T Maeda; K Takagi; M Yoshinaga
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

3.  Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).

Authors:  J Kadota; Y Matsubara; Y Ishimatsu; M Ashida; K Abe; R Shirai; K Iida; K Kawakami; H Taniguchi; T Fujii; M Kaseda; S Kawamoto; S Kohno
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

4.  Role of interleukin-1 in the pathogenesis of experimental shigellosis.

Authors:  P J Sansonetti; J Arondel; J M Cavaillon; M Huerre
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.